Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy
Conferences
Nelson, C; Gemberling, M; Oliver, ML; Hakim, CH; Rivera, RMC; Asokan, A; Duan, D; Gersbach, CA
Published in: MOLECULAR THERAPY
May 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
431 / 432
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Nelson, C., Gemberling, M., Oliver, M. L., Hakim, C. H., Rivera, R. M. C., Asokan, A., … Gersbach, C. A. (2018). Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy. In MOLECULAR THERAPY (Vol. 26, pp. 431–432). Chicago, IL: CELL PRESS.
Nelson, Christopher, Matthew Gemberling, Matthew L. Oliver, Chady H. Hakim, Ruth M Castellanos Rivera, Aravind Asokan, Dongsheng Duan, and Charles A. Gersbach. “Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy.” In MOLECULAR THERAPY, 26:431–32. CELL PRESS, 2018.
Nelson C, Gemberling M, Oliver ML, Hakim CH, Rivera RMC, Asokan A, et al. Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy. In: MOLECULAR THERAPY. CELL PRESS; 2018. p. 431–2.
Nelson, Christopher, et al. “Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy.” MOLECULAR THERAPY, vol. 26, no. 5, CELL PRESS, 2018, pp. 431–32.
Nelson C, Gemberling M, Oliver ML, Hakim CH, Rivera RMC, Asokan A, Duan D, Gersbach CA. Long-Term Evaluation of Genome Editing Outcomes for Duchenne Muscular Dystrophy. MOLECULAR THERAPY. CELL PRESS; 2018. p. 431–432.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
May 1, 2018
Volume
26
Issue
5
Start / End Page
431 / 432
Location
Chicago, IL
Publisher
CELL PRESS
Conference Name
21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy (ASGCT)
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics